Get Started

CTMX

NASD CytomX Therapeutics, Inc.
Nov 11, 2026 · 8:11 PM ET LAST TRADE Market Closed

$2.17 ↑ +0.04 (+1.88%) Trading Up from the previous close of $2.13, and at the day’s high of $2.17

YTD change
-49.06%
vs 20-day SMA
-4.63%
vs 200-day SMA
-42.36%

Price ranges

Previous day
$1.90 $2.02
open $1.95 close $1.98
+$0.03 (+1.54%)
Today
$1.96 $2.17
open $1.99 now $2.17
+$0.18 (+9.05%)
Past week
$1.90 $2.36
from $2.18 now $2.17
-$0.01 (-0.46%)
Past month
$1.90 $2.61
from $2.33 now $2.17
-$0.16 (-6.67%)
This year
$1.90 $8.21
from $4.26 now $2.17
-$2.09 (-49.06%)

Price & Performance

-1.88 (-48.70%) / 6M

$1.82$2.59$3.35$4.11May 11Aug 11Nov 10

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 93.8% away from all-time highs of $35.00
  • CTMX is down 49% since the beginning of the year
  • CTMX is down 47% over the past 12 months
  • CTMX is down 7% over the past 1 month
  • 20% of all CTMX investors are betting against CTMX

CTMX reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -51.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.09
Earnings momentum -7.2% Quarterly EPS growth
Quarterly change -7.2%

Valuation

P/E ratio N/A
Enterprise value $89.3M
Beta 4.23

Balance sheet & scale

IncomeN/A
Revenue$14.0M
Cash$348.9M
Debt$4.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $473.1M

CytomX Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies to address unmet need in oncology. The firm focuses on the field of antibody masking technologies through the development of its Probody therapeutic platform. The company was founded by Frederick W. Gluck, Nancy E. Stagliano, and Patrick S. Daugherty in February 2008 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.23 +0.00%
MRNA Moderna, Inc. $250.83 -6.75%
RVMD Revolution Medicines, Inc. $193.06 -3.54%
ROIV Roivant Sciences Ltd. $41.19 +1.28%
BNTX BioNTech SE Sponsored ADR $87.21 -0.34%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.